whether
also
play
role
stimul
human
monocyt
major
reservoir
known
show
human
monocyt
constitut
express
select
trigger
cell
produc
effect
express
observ
transcript
level
primarili
depend
activ
transcript
factor
increas
bind
activ
complex
timeand
dosedepend
manner
delet
bind
site
promot
result
lack
transcript
particular
bind
site
locat
posit
seem
essenti
mrna
induct
monocyt
ever
increas
amount
evid
show
tight
link
biolog
dysregul
monocyt
activ
releas
pathogenesi
overal
result
suggest
may
play
critic
role
monocytemedi
inflammatori
process
suspect
major
precipit
event
aidsdefin
diseas
nuclear
extract
mg
protein
per
sampl
obtain
describ
monocyt
cell
treat
induc
activ
blood
monocyt
major
vivo
cell
target
infect
known
less
suscept
viral
cytopath
effect
resist
apoptosi
lymphocyt
herbein
et
al
kedzierska
et
al
due
abil
surviv
infect
chronic
lowlevel
viral
infect
monocyt
serv
major
viru
reservoir
ho
et
al
activ
monocyt
infecti
andor
inflammatori
stimuli
increas
plasma
viral
load
donovan
et
al
goletti
et
al
combin
increas
number
cell
addit
activ
monocyt
traffic
invad
tissu
organ
home
site
infect
inflamm
fischersmith
et
al
product
infect
monocyt
may
therefor
ultim
serv
trojan
hors
viral
dissemin
differ
organ
furthermor
monocytedepend
mechan
viral
amplif
local
site
initi
infect
appear
prerequisit
effici
dissemin
infect
hirsch
et
al
analysi
infect
monocyt
reveal
evid
signal
cascad
lead
upregul
specif
inflammationrel
molecul
includ
wahl
et
al
play
import
role
sustain
inflamm
replic
fantuzzi
et
al
also
involv
mass
recruit
target
dendrit
cell
monocyt
macrophag
lymphocyt
local
site
infect
cinqu
et
al
fantuzzi
et
al
alfano
poli
role
confirm
recent
find
infect
diseas
progress
influenc
mutant
allel
link
increas
monocyt
infiltr
tissu
level
gonzalez
et
al
consider
attent
therefor
given
mechan
trigger
induc
enhanc
product
monocyt
matrix
protein
structur
protein
play
import
part
life
cycl
retroviru
fiorentini
et
al
releas
infect
cell
fiorentini
et
al
recent
shown
accumul
lymph
node
absenc
detect
replic
popov
et
al
recombin
protein
exert
cytokinelik
activ
bind
specif
cellular
receptor
de
francesco
et
al
abl
modul
activ
prolifer
statu
nk
cell
de
francesco
et
al
vital
et
al
enhanc
replic
de
francesco
et
al
moreov
increas
releas
proinflammatori
molecul
tnfa
ifng
counteract
antiinflammatori
activ
de
francesco
et
al
like
releas
proinflammatori
molecul
may
induc
activ
monocyt
modul
function
howev
potenti
direct
effect
monocyt
yet
investig
studi
show
human
monocyt
constitut
express
surfac
capabl
trigger
monocyt
select
produc
furthermor
show
induct
product
depend
activ
cellular
transcript
factor
biotinconjug
allow
react
viabl
peripher
blood
mononuclear
cell
pbmc
obtain
healthi
donor
shown
fig
left
cell
stain
monoclon
antibodi
mab
reveal
almost
monocyt
constitut
express
surfac
presenc
human
monocyt
confirm
cell
purifi
magnet
sort
use
paramagnet
bead
specif
reagent
fig
right
specif
bind
confirm
displac
interact
mab
data
shown
stabil
phenotyp
evalu
purifi
monocyt
prepar
almost
monocyt
show
phenotyp
h
cultur
mean
fluoresc
intens
mfi
similar
even
higher
observ
cell
soon
purif
fig
right
time
observ
consist
increas
mfi
express
cell
stimul
h
ifng
lp
shown
fig
top
ifng
increas
express
purifi
monocyt
alreadi
dose
low
ng
ml
peak
express
reach
ifng
dose
ng
ml
lp
less
effici
ifng
upregul
express
peak
express
observ
lp
dose
ng
ml
kinet
analysi
express
h
show
express
enhanc
monocyt
within
h
fig
bottom
slow
surfac
induct
therefor
indic
de
novo
synthesi
follow
monocyt
activ
yet
known
surfac
express
regul
therefor
examin
baselin
turnov
purifi
monocyt
cell
cultur
presenc
absenc
protein
synthesi
inhibitor
biotinconjug
allow
react
pbmc
purifi
monocyt
detect
cell
surfac
perform
use
apcconjug
streptavidin
specif
reagent
left
cell
also
stain
fitcconjug
mab
data
display
bivari
dot
plot
show
approxim
monocyt
express
right
express
purifi
monocyt
display
hystogram
histogram
bold
cell
within
freshli
purifi
monocyt
dot
cell
within
purifi
monocyt
stain
unrel
biotinil
protein
solid
cell
within
purifi
monocyt
h
cultur
complet
medium
b
express
purifi
activ
monocyt
cell
cultur
presenc
differ
dose
ifng
lp
assay
express
h
stimul
top
kinet
upregul
cell
stimul
h
optim
dose
ifng
ng
ml
lp
ng
ml
shown
bottom
panel
result
repres
three
independ
experi
cycloheximid
kinet
express
examin
h
timecours
ie
h
anoth
cell
surfac
receptor
name
hladr
includ
comparison
high
stabil
lanzavecchia
et
al
known
recycl
kinet
allophycocyanin
apc
tulp
et
al
shown
fig
cell
treat
cycloheximid
show
downregul
surfac
express
background
level
h
cultur
comparison
hladr
molecul
whose
express
surfac
monocyt
affect
expect
cycloheximid
clearli
show
acceler
turnov
suggest
de
novo
synthesi
requir
maintain
normal
express
level
treatment
monocyt
trypsin
min
reduc
express
almost
background
level
fig
direct
involv
trypsin
degrad
confirm
lack
activ
trypsin
inactiv
soybean
trypsin
inhibitor
moreov
effect
trypsin
due
cell
death
signific
increas
percentag
cell
stain
propidium
iodid
trypsin
treatment
assess
flow
cytometri
data
shown
assess
whether
loss
trypsin
cell
transient
trypsintr
monocyt
allow
recov
differ
period
time
bind
analysi
restor
express
start
approxim
h
cultur
involv
monocyt
wherea
total
recoveri
express
reach
h
cultur
fig
slow
kinet
suggest
protein
synthesi
may
requir
order
complet
exclud
presenc
preform
intracellular
cell
cultur
soon
trypsin
treatment
medium
contain
cycloheximid
reexpress
complet
block
cycloheximid
show
probabl
due
protein
synthesi
rather
mobil
preform
intracellular
pool
character
effect
purifi
monocyt
investig
level
differ
cytokin
chemokin
ie
tnfa
rant
medium
untreat
cell
h
begin
cultur
untreat
monocyt
constitut
releas
rang
ng
per
cell
occasion
also
trace
tnfa
addit
begin
cultur
induc
dosedepend
manner
product
cell
supernat
fig
wherea
affect
level
cytokin
chemokin
test
data
shown
assess
whether
increas
protein
level
induc
treatment
parallel
increas
purifi
monocyt
stain
hladr
express
describ
experiment
procedur
begin
cultur
h
almost
cell
hladr
bold
line
control
dot
line
repres
cell
stain
isotyp
igg
versu
hladr
unrel
biotinyl
protein
versu
cell
cultur
h
presenc
solid
line
absenc
bold
line
cycloheximid
b
treatment
monocyt
trypsin
min
h
reduc
express
bold
line
almost
background
level
dot
line
cell
allow
recov
complet
medium
presenc
solid
line
absenc
bold
line
cycloheximid
monocyt
collect
h
h
trypsin
treatment
stain
result
repres
three
independ
experi
rel
mrna
analys
kinet
mrna
appear
quantit
realtim
pcr
taqman
assay
rtpcr
monocyt
treat
total
rna
extract
cell
lysat
h
begin
cultur
messeng
level
quantifi
accord
bactin
mrna
express
shown
fig
enhanc
mrna
express
increas
start
h
treatment
reach
approxim
eightfold
increas
h
begin
treatment
activ
gene
transcript
differ
cell
system
known
control
cellular
transcript
factor
nfkb
andor
shyy
et
al
assess
mechan
wherebi
induc
increas
gene
express
verifi
whether
treatment
increas
nfkb
dnabind
activ
preliminari
experi
run
use
transsign
array
proteindna
array
includ
among
other
specif
probe
two
transcript
factor
shown
fig
nuclear
extract
untreat
monocyt
show
basal
level
dna
fig
induct
product
monocyt
purifi
monocyt
obtain
eight
healthi
donor
treat
concentr
mg
ml
cultur
supernat
collect
h
begin
cultur
analys
presenc
standard
quantit
elisa
bar
repres
mean
valu
sampl
pvalu
calcul
wilcoxon
test
b
cell
treat
mg
ml
harvest
specifi
time
bactin
level
analys
taqman
rtpcr
mrna
level
normal
bactin
level
sampl
express
fold
induct
level
detect
cell
time
point
bar
repres
mean
sd
triplic
sampl
fig
activ
human
monocyt
nuclear
protein
extract
obtain
monocyt
collect
treatment
mg
ml
analys
bind
activ
oligonucleotid
specif
differ
transcript
factor
repres
fluorogram
proteindna
array
analysi
nfkb
dnabind
activ
nuclear
extract
mg
per
sampl
human
monocyt
collect
h
treatment
transcript
factor
evalu
duplic
concentr
concentr
specif
oligonucleotid
b
repres
emsa
autoradiogram
use
nuclear
extract
mg
per
sampl
human
monocyt
collect
specifi
time
treatment
radiolabel
oligonucleotid
c
cell
proteindna
complex
specif
confirm
competit
excess
unlabel
oligonucleotid
probe
dnabind
activ
use
load
control
right
panel
show
densitometr
analysi
chang
dnabind
activ
rel
express
fold
induct
control
untreat
cell
c
protein
famili
profil
dnabind
activ
elisabas
transcript
factor
assay
kit
use
nuclear
extract
mg
per
sampl
human
monocyt
cultur
h
presenc
absenc
oligonucleotid
immobil
plate
level
fo
jun
famili
member
activ
complex
untreat
monocyt
express
percentag
rel
activ
refer
h
valu
statist
analysi
perform
oneway
anova
test
p
statist
differ
compar
h
valu
bar
repres
mean
sd
triplic
sampl
repres
data
one
three
experi
shown
bind
activ
enhanc
treatment
h
convers
treatment
monocyt
modifi
nfkb
dnabind
activ
howev
present
low
level
basal
condit
data
obtain
proteindna
array
analysi
confirm
electrophoret
mobil
shift
assay
emsa
preliminari
experi
use
concentr
rang
mg
ml
show
activ
dnabind
activ
dosedepend
manner
peak
mg
ml
dose
data
shown
timecours
analysi
use
mg
ml
show
activ
activ
also
timedepend
peak
approxim
threefold
increas
h
begin
treatment
declin
fig
specif
proteindna
complex
confirm
competit
experi
use
excess
specif
unlabel
oligonucleotid
protein
bind
dna
homoor
heterodim
jun
cjun
jund
junb
fo
cfo
fosb
protooncogen
famili
experi
perform
character
protein
involv
proteindna
complex
data
obtain
famili
transcript
factor
assay
show
cfo
fosb
junb
main
compon
complex
fig
due
larg
number
primari
monocyt
requir
analysi
transcript
factor
dnabind
activ
protein
nuclear
extract
investig
involv
transcript
factor
transcript
event
use
monocyt
cell
line
constitut
express
surfac
data
shown
result
emsa
experi
show
treatment
cell
h
mg
ml
induc
activ
peak
increas
h
treatment
induc
nfkb
activ
fig
emsa
experi
show
pretreat
exogen
protein
neutral
mab
block
activ
data
shown
analys
perform
character
specif
protein
composit
complex
induc
treatment
cell
analysi
show
preferenti
involv
cfo
junb
activ
complex
fig
altogeth
result
confirm
similar
activ
pattern
human
primari
monocyt
cell
suggest
cell
line
may
use
model
futur
studi
biolog
activ
monocyt
compart
cell
also
use
target
assess
stabil
heat
enzymat
degrad
therefor
treat
exogen
trypsin
h
boil
min
treatment
complet
abolish
activ
assess
emsa
fig
provid
evid
viral
protein
sensit
proteas
heat
denatur
activ
cell
nuclear
protein
extract
cell
collect
differ
time
treatment
mg
ml
analys
bind
activ
oligonucleotid
specif
differ
transcript
factor
repres
autoradiogram
emsa
use
nuclear
extract
mg
per
sampl
cell
specifi
time
treatment
radiolabel
oligonucleotid
specif
nfkb
c
untreat
cell
lp
lpstreat
cell
mg
ml
lp
h
use
posit
control
nfkb
activ
proteindna
complex
specif
confirm
competit
excess
unlabel
oligonucleotid
probe
right
panel
repres
densitometr
analysi
chang
dnabind
activ
rel
use
load
control
data
express
fold
induct
control
untreat
cell
b
famili
profil
dna
bind
activ
elisabas
kit
use
nuclear
extract
mg
per
sampl
cell
cultur
h
presenc
absenc
oligonucleotid
immobil
plate
level
fo
jun
famili
member
activ
complex
untreat
monocyt
express
percentag
rel
activ
refer
h
valu
statist
analysi
perform
oneway
anova
test
p
statist
differ
compar
h
valu
bar
repres
mean
sd
three
separ
experi
triplic
c
repres
emsa
autoradiogram
use
nuclear
extract
cell
collect
specifi
time
treatment
boil
trypsin
oligonucleotid
specif
load
control
human
gene
contain
one
bind
site
enhanc
region
two
bind
site
promot
region
investig
region
involv
transcript
activ
primari
monocyt
transfect
differ
plasmid
contain
report
luciferas
gene
clone
downstream
promot
promot
luciferas
report
plasmid
use
includ
pglmprm
contain
proxim
promot
region
gene
pglmenh
contain
proxim
promot
distal
enhanc
region
mutat
bind
site
plasmid
contain
proxim
promot
region
whose
bind
site
delet
fig
flow
cytometr
analysi
cell
transfect
control
gfpencod
plasmid
pmaxgfp
show
high
transfect
effici
primari
monocyt
viabl
cell
express
gfp
earli
h
pmaxgfp
plasmid
transfect
fig
soon
transfect
cell
left
untreat
treat
mg
ml
pma
ng
ml
tnfa
ng
ml
use
control
nfkb
activ
pma
tnfa
result
signific
transcript
activ
respect
cell
transfect
pglmenh
plasmid
promot
enhanc
region
present
shown
monocyt
luciferas
activ
construct
pglmenh
pglmprm
induc
approxim
twofold
fig
lack
differ
promot
enhanc
region
respons
despit
potenti
bind
site
enhanc
region
indic
critic
role
bind
site
promot
region
inde
delet
bind
site
result
complet
loss
activ
assess
whether
express
depend
bind
site
mutat
region
pglmprm
plasmid
test
activ
treatment
result
luciferas
express
cell
transfect
pgmlprm
plasmid
find
suggest
bind
site
promot
region
necessari
optim
stimul
monocytemedi
inflammatori
process
product
like
major
precipit
event
fig
analysi
transcript
activ
schemat
represent
four
human
report
construct
use
perform
experi
pglenh
contain
proxim
promot
distal
enhanc
region
construct
three
bind
site
identifi
open
box
locat
enhanc
region
place
promot
region
pglprm
contain
proxim
promot
region
wherea
mut
contain
proxim
promot
region
mutat
bind
site
construct
delet
bind
site
b
transfect
effici
purifi
human
monocyt
assess
flow
cytometri
use
gfpexpress
plasmid
tracer
left
panel
gfp
monocyt
display
bold
histogram
oppos
untransfect
cell
thin
line
percentag
gfp
cell
also
report
transfect
nucleofect
impair
express
surfac
monocyt
right
cell
transfect
pmaxgfp
plasmid
stain
biotinconjug
apcconjug
streptavidin
detect
express
pi
mark
dead
cell
viabl
monocyt
pi
gate
fscpi
dot
plot
shown
analysi
perform
gfp
versu
dot
plot
quadrant
statist
shown
c
purifi
human
monocyt
transient
cotransfect
prltk
control
vector
togeth
one
plasmid
describ
soon
transfect
cell
treat
mg
ml
renilla
firefli
luciferas
activ
determin
h
treatment
rel
activ
express
fold
stimul
describ
experiment
procedur
repres
mean
sd
quadrupl
sampl
three
independ
experi
aid
pathogenesi
increas
amount
evid
show
tight
link
activ
monocyt
recruit
releas
pathogenesi
especi
aid
patient
suffer
dementia
select
accumul
cerebrospin
fluid
aid
patient
togeth
find
level
correl
degre
dementia
cinqu
et
al
conant
et
al
kelder
et
al
substanti
possibl
role
neuropathogenesi
worth
note
presenc
activ
monocyt
brain
better
correl
extent
viral
infect
glass
et
al
chronic
inflammatori
state
circul
monocyt
emerg
time
also
patient
receiv
highli
activ
antiretrovir
therapi
haart
particular
element
evolv
chronic
inflammatori
state
character
increas
chemotact
macrophag
marker
matur
monocyt
macrophag
hybrid
profil
pulliam
et
al
consider
interest
focus
therefor
mechan
make
activ
induc
dysregul
monocyt
activ
understand
mechan
contribut
identifi
linkag
infect
monocyt
activ
ultim
achiev
improv
control
replic
spread
viru
prevent
treatment
immun
disord
highli
activ
antiretrovir
therapi
usual
lead
prolong
control
replic
yet
block
replic
link
complet
recoveri
immun
dysfunct
thu
suggest
mechan
activ
viral
replic
involv
chronic
immun
perturb
structur
protein
associ
immun
activ
loss
function
compet
differ
immun
cell
quaranta
et
al
among
matrix
protein
recent
identifi
critic
determin
aid
pathogenesi
bind
cellular
receptor
express
immun
cell
enhanc
viral
replic
infect
de
francesco
et
al
combin
differ
effector
function
de
francesco
et
al
vital
et
al
structur
viral
protein
accumul
persist
lymph
node
patient
haart
popov
et
al
moreov
amount
protein
notic
differ
lymph
node
specimen
either
initi
therapi
treatment
viru
burden
significantli
decreas
find
strongli
suggest
persist
patient
haart
long
time
absenc
detect
viru
replic
make
conceiv
chronic
activ
immun
cell
lead
immun
dysfunct
furthermor
recent
shown
releas
infect
cell
fiorentini
et
al
detect
sera
obtain
patient
use
newli
develop
captur
immunoassay
fiorentini
et
al
prepar
proinflammatori
role
suggest
abil
induc
tnfa
ifng
express
cell
counteract
antiinflammatori
activ
de
francesco
et
al
present
studi
describ
abil
matrix
protein
perturb
biolog
activ
primari
monocyt
select
induc
increas
product
releas
process
mediat
express
monocyt
surfac
biolog
activ
exert
bind
specif
receptor
absent
rest
cell
express
activ
cell
accordingli
activ
observ
preactiv
cell
mitogen
per
se
exert
biolog
effect
vitro
biolog
activ
therefor
describ
far
synergist
effect
complet
separ
trigger
mitogen
studi
show
circul
monocyt
constitut
express
surfac
first
time
further
understand
signal
trigger
interact
trypsinsensit
membran
protein
shown
involv
bind
human
monocyt
reexpress
monocyt
trypsin
treatment
requir
sever
hour
impair
cycloheximid
suggest
de
novo
protein
synthesi
need
maintain
express
monocyt
rather
mobil
intracellular
store
interestingli
express
term
mean
fluoresc
intens
strongli
upmodul
surfac
cell
upon
activ
monocyt
ifng
lp
find
express
increas
two
known
monocyt
stimulatori
molecul
warrant
definit
molecul
new
marker
attest
monocyt
activ
statu
yet
clear
howev
express
specif
sustain
monocyt
cell
sever
signal
pathway
hypothes
transcript
regul
human
gene
tre
kb
enhanc
element
exist
region
gene
thu
suggest
role
nfkb
shyy
et
al
therefor
decid
use
primari
human
monocyt
model
assess
signal
transduct
pathway
involv
gene
express
emsa
reveal
caus
signific
chang
dnabind
activ
nfkb
wherea
increas
bind
timeand
dosedepend
manner
induct
primari
human
monocyt
cell
associ
increas
level
cfo
junb
protein
activ
complex
result
indic
complex
respons
transcript
activ
like
cfosjunb
heterodim
delet
bind
site
induc
activ
enhanc
region
human
mutat
bind
site
proxim
promot
region
effect
transcript
activ
respons
instead
delet
bind
site
promot
region
result
reduc
gene
transcript
level
close
basal
transcript
valu
evid
suggest
upregul
transcript
human
monocyt
may
depend
activ
bind
site
proxim
promot
region
howev
direct
evid
involv
bind
site
transcript
still
lack
effort
obtain
promoterluciferas
construct
contain
mutat
bind
site
unsuccess
find
suggest
primari
human
monocyt
could
major
regul
transcript
independ
nfkb
activ
line
previou
studi
hanazawa
et
al
wang
et
al
lee
et
al
cho
et
al
moreov
cho
et
al
lim
garzinodemo
clearli
shown
bind
site
abolish
induc
promot
activ
human
endotheli
cell
human
astrocytoma
cell
respect
taken
togeth
result
suggest
least
certain
cell
activ
circumv
nfkb
pathway
mean
differ
signal
transduct
pathway
lead
induct
gene
interestingli
experi
show
peak
activ
h
stimul
persist
lower
level
h
time
transcript
increas
h
treatment
reach
plateau
h
stimul
kinet
activ
appar
well
correl
induct
gene
find
may
reflect
capabl
trigger
unusu
pathway
induc
bind
promot
lead
product
transcript
also
stabil
ultim
allow
accumul
inde
well
known
regul
transcript
due
gene
transcript
activ
mrna
posttranscript
stabil
differ
studi
demonstr
upon
differ
exogen
stimuli
mrna
halflif
increas
h
antiinflammatori
molecul
may
reduc
min
poon
et
al
dhawan
et
al
hand
complet
rule
possibl
may
activ
transcript
factor
cooper
determin
prolong
activ
transcript
import
note
sever
virus
report
modul
activ
sadowska
et
al
kwon
et
al
xie
et
al
holloway
coulson
case
viral
protein
respons
activ
identifi
eg
hepat
b
viru
x
protein
tanaka
et
al
sever
acut
respiratori
syndrom
sar
coronaviru
nucleocapsid
protein
et
al
papilloma
viru
protein
behren
et
al
epsteinbarr
viru
latent
protein
parvoviru
nonstructur
protein
ns
kieser
et
al
common
exploit
pathway
point
wider
role
signal
event
downstream
gene
target
viral
infect
case
activ
redund
phenomenon
perform
viral
protein
tat
kumar
et
al
nef
bigg
et
al
gibellini
et
al
vpr
varin
et
al
shown
matrix
protein
case
activ
may
enhanc
viral
replic
via
transactiv
rabbi
et
al
demonstr
may
also
modul
express
cellular
gene
effect
could
promot
infect
also
lead
function
defect
pathogenet
event
demonstr
contribut
pathogenesi
aid
dementia
result
suggest
necessari
block
biolog
activ
protein
includ
continu
releas
infect
cell
despit
success
block
viral
replic
obtain
haart
time
knowledg
induc
monocyt
produc
activ
transcript
factor
follow
new
therapeut
strategi
capabl
neutral
function
molecul
induc
protein
known
contributor
virul
pathogenesi
purifi
endotoxinfre
recombin
matrix
protein
produc
describ
previous
de
francesco
et
al
aliquot
purifi
prepar
biotinyl
use
ahnhsbiotin
biospa
milan
itali
accord
manufactur
instruct
recombin
human
ifng
tnfa
obtain
r
system
minneapoli
mn
usa
lp
escherichia
coli
phorbol
pma
cycloheximid
suppli
sigmaaldrich
milan
itali
mab
recogn
epitop
respons
bind
neutral
interact
de
francesco
et
al
produc
purifi
laboratori
peripher
blood
mononuclear
cell
pbmc
isol
densiti
gradient
centrifug
blood
healthi
donor
gave
inform
consent
research
helsinki
declar
cell
plate
onto
tissu
cultur
dish
supplement
vv
fetal
calf
serum
fc
invitrogen
milan
itali
u
ml
penicillin
mg
ml
streptomycin
mm
lglutamin
complet
medium
monocyt
purifi
pbmc
use
microbead
kit
miltenyi
biotec
bologna
itali
automac
miltenyi
biotec
accord
manufactur
instruct
puriti
monocyt
assess
overnight
incub
complet
medium
stain
flow
cytometri
found
greater
human
monocyt
cell
line
gift
dr
maura
ferrari
istituto
zooprofilattico
sperimental
brescia
itali
cell
grown
maintain
cultur
complet
medium
stain
cell
express
perform
alreadi
describ
previous
de
francesco
et
al
briefli
cell
incub
min
ice
biotinconjug
recombin
concentr
ng
ml
wash
pb
contain
fc
incub
min
ice
apcconjug
streptavidin
bd
bioscienc
milan
itali
experi
perform
pbmc
cell
stain
min
ice
fitcconjug
mab
identifi
monocyt
data
obtain
analys
cellquest
softwar
bd
bioscienc
experi
cell
also
counterstain
peconjug
antihladr
mab
bd
bioscienc
purifi
monocyt
treat
ml
trypsin
solut
sigmaaldrich
min
proteas
activ
stop
addit
icecold
complet
medium
soybean
trypsin
inhibitor
sbti
type
ii
sigmaaldrich
control
cell
treat
buffer
use
combin
trypsin
sbti
ad
simultan
proteasetr
cell
wash
twice
subsequ
assay
express
describ
viabil
cell
determin
propidium
iodid
mg
ml
stain
flow
cytometr
analysi
experi
measur
recoveri
express
trypsin
treatment
cell
resuspend
concentr
cell
ml
complet
medium
incub
h
experi
monocyt
cultur
presenc
cycloheximid
mg
ml
sigmaaldrich
rant
mrna
level
determin
quantit
rtpcr
total
rna
extract
untreat
monocyt
use
trizol
rna
isol
kit
invitrogen
accord
manufactur
instruct
revers
transcript
use
improm
revers
transcriptas
promega
milan
itali
rel
amount
rant
bactin
mrna
determin
rtpcr
amplif
carri
ml
reaction
mix
contain
ml
taqman
univers
pcr
master
mix
appli
biosystem
monza
itali
ml
primer
fam
dyelabel
probe
gene
express
assay
appli
biosystem
rtpcr
assay
perform
triplic
rtpcr
system
appli
biosystem
follow
programm
cycl
min
analysi
rtpcr
data
perform
ddct
method
use
rel
quantit
studi
softwar
appli
biosystem
quantif
chemokin
cdna
normal
reaction
accord
intern
bactin
control
level
chemokin
mrna
express
fold
differ
cell
comparison
untreat
cell
calibr
sampl
cytokin
chemokin
name
tnfa
rant
evalu
supernat
monocyt
cultur
presenc
absenc
concentr
rang
mg
ml
searchlight
chemiluminesc
array
endogen
rockford
il
experi
quantif
supernat
untreat
monocyt
perform
use
quantit
elisa
kit
endogen
treatment
condit
nuclear
extract
cell
primari
blood
monocyt
prepar
cell
respect
cell
wash
icecold
pb
lyse
ice
min
pack
cell
volum
lysi
buffer
contain
mm
hepe
ph
mm
mm
kcl
mm
egta
mm
dtt
nonidet
proteas
inhibitor
cocktail
sigmaaldrich
nuclei
pellet
centrifug
rpm
min
resuspend
pack
nuclear
volum
highsalt
buffer
contain
mm
hepe
ph
mm
edta
mm
egta
mm
nacl
glycerol
mm
dtt
proteas
inhibitor
cocktail
suspens
rock
min
gentli
vortex
subsequ
centrifug
rpm
min
supernatantnuclear
extract
collect
store
aliquot
protein
concentr
determin
use
biorad
protein
assay
kit
biorad
hercul
ca
nuclear
extract
mg
protein
per
sampl
prepar
describ
incub
biotinyl
dna
oligonucleotid
select
transcript
factor
bind
element
sequenc
transsign
array
panom
redwood
citi
ca
isol
proteindna
complex
sampl
denatur
retain
bind
element
hybrid
membran
contain
complementari
sequenc
hybrid
biotinyl
oligonucleotid
visual
use
horseradish
peroxidas
hrp
conjug
streptavidin
ecl
reagent
panom
transcript
factor
quantifi
duplic
concentr
duplic
oligonucleotid
concentr
condit
mg
ml
incub
plabel
nfkb
dna
probe
tiberio
et
al
mobil
dnaprotein
complex
emsa
analys
describ
previous
tiberio
et
al
experi
recombin
boil
min
treat
trypsin
min
proteas
activ
stop
addit
icecold
complet
medium
competit
experi
excess
specif
unlabel
probe
incub
nuclear
extract
addit
radiolabel
probe
load
control
nuclear
extract
analys
also
dnabind
activ
whose
site
present
mani
housekeep
gene
tiberio
et
al
autoradiograph
signal
quantifi
molecular
dynam
phosphoimag
mdp
analysi
typhoon
molecular
dynam
sunnyval
ca
order
quantifi
activ
assess
natur
dimer
complex
induc
use
elisabas
kit
activ
motif
carlsbad
ca
consist
oligonucleotid
contain
tissuetyp
plasminogen
activ
tpa
respons
element
tre
immobil
solid
phase
assay
run
accord
manufactur
instruct
briefli
nuclear
extract
obtain
monocyt
cell
treat
h
allow
interact
trecoat
well
mg
nuclear
extract
per
well
dimer
contain
nuclear
cell
extract
detect
use
antibodi
direct
cfo
fosb
phospho
cjun
junb
jund
antibodi
bind
complex
detect
ad
hrpconjug
secondari
antibodi
promoterluciferas
construct
contain
proxim
promot
pglmprm
distal
enhanc
pglmenh
region
kindli
provid
dr
yoshimura
laboratori
immunobiolog
nation
cancer
institut
frederick
md
alreadi
describ
ueda
et
al
sitedirect
mutat
introduc
bind
site
promot
region
quickchang
sitedirect
mutagenesi
kit
stratagen
la
jolla
ca
briefli
ng
pglprm
ng
oligonucleotid
ccc
act
tat
gac
aga
tgg
aag
atc
cct
ggg
atc
ttc
cat
ctg
tca
taa
gtg
ggc
incub
u
pfu
dna
polymeras
cycl
time
follow
condit
denatur
anneal
min
extens
min
reaction
mix
cool
ice
min
digest
u
dpni
h
ml
reaction
mix
transform
e
coli
supercompet
cell
plasmid
isol
coloni
grown
overnight
ampicillin
agar
plate
sequenc
carri
identifi
contain
target
mutat
sequenc
interest
plasmid
contain
delet
bind
site
kindli
provid
dr
garzinodemo
institut
human
virolog
univers
maryland
baltimor
md
previous
describ
lim
garzinodemo
purifi
monocyt
cotransfect
nucleofect
use
human
monocyt
kit
amaxa
ag
cologn
germani
individu
luciferas
firefli
test
plasmid
mg
ml
renilla
luciferas
express
plasmid
prltk
intern
control
signal
total
cellular
transcript
level
promega
cell
plate
plate
cell
per
well
expos
mg
ml
complet
medium
h
harvest
luciferas
express
quantifi
use
dualluciferas
report
assay
system
accord
manufactur
instruct
promega
test
valu
correct
luciferas
activ
valu
intern
control
plasmid
prltk
result
expos
cell
express
fold
induct
luciferas
activ
construct
control
condit
take
control
ad
valu
